By accepting this document, you agree that the information contained herein will not be disclosed to others without written authorization from the lead site/sponsor, except to the extent necessary to initiate the study or conduct study -related activities. Androgen suppression with prostate GVAX and cyclophosphamide J1265 Johns Hopkins University 3 of 68 J1265 PROT (Vers) 1.4 113012 SYNOPSIS Title A neoadjuvant immunologic study of androgen suppression combined with a GM -CSF– secreting allogeneic prostate cancer vaccine and low -dose cyclophosphamide in men with high -risk localized prostate cancer undergoing radical prostatectomy Institution Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD PI(s) Emmanuel S. Antonarakis, MD (P I); and Edward M.